One year clinical outcomes with a novel canaloplasty device in mild to severe open angle glaucoma
Canaloplasty using the STREAMLINE® surgical system combined with CE effectively reduces IOP at one year in mild to severe OAG with minimal complications. IOP lowering efficacy, reduction in IOP lowering medications, and safety in moderate to severe OAG require further study.
Authors
- Leonard K. Seibold
- Iden Amiri (ORCID: https://orcid.org/0009-0008-4140-696X)
Institutions
- University of Colorado Denver (US)
Publication Details
- Journal
- International Journal of Ophthalmology
- Published
- 2025-08-18
- DOI
- https://doi.org/10.18240/ijo.2025.09.08
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00